Joseph Michael Fitzgerald Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 3 hours ago
Joseph Michael Fitzgerald has an estimated net worth of at least $49.7 million*, as of Feb. 19, 2025. They own 181,382 shares of BSX stock. They have sold 504,239 shares of BSX stock since 2021, for an estimated $30.6 million.
Joseph Michael Fitzgerald $BSX SEC Form 4 Insider Trading
Joseph Michael Fitzgerald has filed a total of 10 insider trades in $BSX since 2021. Their most recent trade was a sale of 20 shares, made on Dec 10, 2024. Their largest trade was a sale of 132,527 shares, made on Oct 07, 2024. We estimate that they now own 181,382 shares of $BSX, worth an estimated $19.1 million.
Insider Trading at $BSX
There have been a total of 168 insider trades reported at $BSX since 2021, with 25,050 shares purchased and 4.5 million shares sold. The most active insider traders in $BSX stock have been Wendy Carruthers, Jeffrey B. Mirviss, and Michael F Mahoney. The most recent trade was a sale of 3,303 shares reported by John Bradley Sorenson (EVP, Global Operations), made on Feb 19, 2025.
History of Insider Stock Trades by Joseph Michael Fitzgerald
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
BSX
|
Sale | 20 | Dec 10, 2024 | Feb. 13, 2025, 5:32 p.m. |
|
BSX
|
Purchase | 50 | Dec 03, 2024 | Feb. 13, 2025, 5:32 p.m. |
|
BSX
|
Sale | 132,527 | Oct 07, 2024 | Oct. 8, 2024, 5:48 p.m. |
|
BSX
|
Sale | 14,132 | Aug 28, 2024 | Aug. 29, 2024, 4:13 p.m. |
|
BSX
|
Sale | 11,660 | Jan 12, 2024 | Jan. 16, 2024, 5:39 p.m. |
|
BSX
|
Sale | 81,940 | Dec 29, 2023 | Jan. 2, 2024, 9:30 p.m. |
|
BSX
|
Sale | 15,867 | Sep 20, 2023 | Sept. 21, 2023, 4:09 p.m. |
|
BSX
|
Sale | 63,339 | May 16, 2023 | May 17, 2023, 4:30 p.m. |
|
BSX
|
Sale | 79,264 | Dec 13, 2022 | Dec. 14, 2022, 5:37 p.m. |
|
BSX
|
Sale | 105,490 | Jul 27, 2021 | July 26, 2021, 8 p.m. |
$BSX Executives and Stock Owners with Insider Trades
-
Wendy Carruthers, EVP, Human Resources
-
Jeffrey B. Mirviss, EVP&Pres, Periph Intervent
-
Michael F Mahoney, Chairman, President & CEO
-
Daniel J. Brennan, EVP and CFO
-
Arthur C Butcher, EVP& Grp Pres, MedSurg & APAC
-
Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology
-
John Bradley Sorenson, EVP, Global Operations
-
Wendy Carruthers, SVP, Human Resources
-
David A Pierce, EVP Pres MedSurg
-
Jodi Euerle Eddy, SVP, Chief Info & Digital Off.
-
Eric Francis Yves Thepaut, EVP & Pres, Eur, Mid-East, Afr
-
Jonathan Monson, VP, Global Controller and CAO
-
Vance R Brown, SVP, GC and Corp. Secretary
-
Arthur C Butcher, EVP&Pres, Asia Pacific
-
Meghan Scanlon, SVP,Pres,Urology Pelvic Health
-
Scott Olson, SVP & Pres, CRM, Diagnostics
-
Scott Olson, SVP & Pres, Rhythm Management
-
Jonathan Monson, SVP, Global Controller and CAO
-
Ian T Meredith, EVP Global Chief Med Officer
-
John Bradley Sorenson, SVP, Global Supply Chain
-
Emily Woodworth, SVP, Global Controller and CAO
-
Joseph Michael Fitzgerald, EVP & Pres, Interven Cardio
-
Maulik Nanavaty, SVP & Pres, Neuromodulation
-
Edward F Mackey, EVP, Operations
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.